Literature DB >> 14612338

Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine.

Y K Katare1, Amulya K Panda, Komal Lalwani, Irshad Ul Haque, Mushir M Ali.   

Abstract

Poly(lactide) (PLA) polymer particles entrapping immunoreactive tetanus toxoid (TT) were used for generation of immune response using single point immunization. Immunization with different sizes of polymer particles encapsulating immunoreactive TT elicited anti-TT antibody titers that persisted for more than 5 months. However, antibody response generated by single point immunization of either nanoparticles or microparticles were lower than the conventional two doses of alum adsorbed TT. To overcome this limitation, alum was used with particles that improved anti-TT antibody response. Immunization with nanoparticles along with alum resulted in very high and early immune response: high anti-TT antibody titers were detected as early as 15 days postimmunization. However anti-TT antibody titers declined rapidly with time. Immunization with admixture of microparticles and alum elicited higher antibody titers than the particles alone and the antibody titers were high particularly during the later part of the postimmunization period. Single point immunization with admixture of PLA microparticles and alum resulted in an antibody response very close to that achieved by two injection of alum-adsorbed TT. Physical mixture of both a nano- and microparticles along with alum resulted in sustained anti-TT antibody response from very early days of postimmunization until 150 days. The antibody titers were maintained around 50 microg/ml for more than 5 months. These results indicated that immune response from polymer particles can be further improved by use of additional adjuvant. Furthermore, using various size particles or physical mixture of different size particles along with alum, it is possible to modulate the kinetics of immune response using polymer particles based immunization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612338     DOI: 10.1080/drd_10_4_231

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  6 in total

Review 1.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 2.  Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

Authors:  Stacey L Demento; Alyssa L Siefert; Arunima Bandyopadhyay; Fiona A Sharp; Tarek M Fahmy
Journal:  Trends Biotechnol       Date:  2011-04-02       Impact factor: 19.536

3.  Toward a Single-Dose Vaccination Strategy with Self-Encapsulating PLGA Microspheres.

Authors:  Brittany A Bailey; Lukasz J Ochyl; Steven P Schwendeman; James J Moon
Journal:  Adv Healthc Mater       Date:  2017-04-03       Impact factor: 9.933

4.  Stabilization of tetanus toxoid encapsulated in PLGA microspheres.

Authors:  Wenlei Jiang; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2008-08-19       Impact factor: 4.939

5.  Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases.

Authors:  Christopher J Genito; Cole J Batty; Eric M Bachelder; Kristy M Ainslie
Journal:  Adv Nanobiomed Res       Date:  2021-01-18

Review 6.  Targeting the porcine immune system--particulate vaccines in the 21st century.

Authors:  Kenneth C McCullough; Artur Summerfield
Journal:  Dev Comp Immunol       Date:  2008-09-02       Impact factor: 3.636

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.